| 000 | 01152 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250518073319.0 | ||
| 264 | 0 | _c20200619 | |
| 008 | 202006s 0 0 ita d | ||
| 022 | _a2038-1840 | ||
| 024 | 7 |
_a10.1701/3265.32349 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBanzi, Rita | |
| 245 | 0 | 0 |
_aNone _h[electronic resource] |
| 260 |
_bRecenti progressi in medicina _cNov 2019 |
||
| 300 |
_a526-527 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aCommerce |
| 650 | 0 | 4 |
_aDrug Approval _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 |
_aEvidence-Based Medicine _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aNon-Randomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aObservational Studies as Topic _xmethods |
| 650 | 0 | 4 | _aPharmacovigilance |
| 650 | 0 | 4 |
_aRandomized Controlled Trials as Topic _xmethods |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 773 | 0 |
_tRecenti progressi in medicina _gvol. 110 _gno. 11 _gp. 526-527 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1701/3265.32349 _zAvailable from publisher's website |
| 999 |
_c30392450 _d30392450 |
||